Found this article on the Nasdaq site. It doesn't mention GMV, but does mention several biotech companies which have postponed their IPOs. Maybe it is a bit comforting to see others in the same boat as us. I firmly believe that the IPO will go ahead but may have to be postponed until the full year financials can be released, as they will paint a far better picture of the potential of the company.
https://www.nasdaq.com/articles/us-ipo-weekly-recap%3A-postponements-abound-as-doordash-joins-the-ipo-pipeline-2020-11-14